Anavex Life Sciences Announces ANAVEX®2-73 (Blarcamesine) Meets Primary and Secondary Endpoints in Placebo-Controlled U.S. Phase 2 Clinical Trial for the Treatment of Adult Patients with Rett Syndrome
https://www.anavex.com/anavex-life-...he-treatment-of-adult-patients-with-rett-syn/
- Forums
- ASX - By Stock
- NEU
- ANAVEX MEETS ENDPOINTS PHASE2 RETT
NEU
neuren pharmaceuticals limited
Add to My Watchlist
2.68%
!
$14.56

ANAVEX MEETS ENDPOINTS PHASE2 RETT
-
- There are more pages in this discussion • 107 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$14.56 |
Change
0.380(2.68%) |
Mkt cap ! $1.806B |
Open | High | Low | Value | Volume |
$14.36 | $14.75 | $14.36 | $7.232M | 495.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
17 | 725 | $14.54 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.56 | 478 | 15 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 687 | 14.500 |
9 | 1112 | 14.490 |
7 | 1296 | 14.480 |
8 | 1525 | 14.470 |
7 | 1381 | 14.460 |
Price($) | Vol. | No. |
---|---|---|
14.520 | 599 | 13 |
14.530 | 638 | 6 |
14.540 | 884 | 7 |
14.550 | 1600 | 9 |
14.560 | 1357 | 6 |
Last trade - 14.04pm 10/07/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |